| Androxal (enclomifene) / AbbVie |
NCT00706719: To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone |
|
|
| Completed | 2b | 17 | US | 25 mg Androxal, Enclomiphene citrate, Testim 1%, Topical testosterone | Repros Therapeutics Inc. | Secondary Hypogonadism | 07/09 | 08/09 | | |
NCT01270841: Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism |
|
|
| Completed | 2b | 83 | US | Placebo, topical testosterone, Testim, AndroGel, Androxal, Enclomiphene citrate | Repros Therapeutics Inc. | Secondary Hypogonadism | 12/11 | 12/11 | | |
| Withdrawn | 2b | 0 | US | Enclomiphene citrate, Androxal, Placebo, sugar pill | Baylor College of Medicine | Infertility | 08/16 | 08/16 | | |
NCT01386606: The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone) |
|
|
| Completed | 2 | 60 | US | Androxal (enclomiphene citrate), Androxal, low testosterone therapy, Testosterone, topical testosterone, testosterone gel, exogenous testosterone | Repros Therapeutics Inc. | Secondary Hypogonadism | 10/11 | 10/11 | | |
NCT01191320: Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus |
|
|
| Completed | 2 | 102 | US | Placebo, Androxal, Enclomiphene citrate | Repros Therapeutics Inc. | Type 2 Diabetes Mellitus, Secondary Hypogonadism | 12/11 | 12/11 | | |
NCT01386567: A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203 |
|
|
| Completed | 2 | 48 | US | Androxal (enclomiphene citrate), enclomiphene citrate, Testim (topical testosterone), topical testosterone, exogenous testosterone, testosterone gel | Repros Therapeutics Inc. | Hypogonadism, Low Testosterone | 01/13 | 01/13 | | |
